We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1,810.00 | 1,810.00 | 1,810.50 | 1,814.50 | 1,806.50 | 1,811.00 | 466,178 | 09:40:43 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 15.14 | 74.62B |
TIDMGSK
RNS Number : 6785M
GlaxoSmithKline PLC
17 September 2019
1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================== a) Name Mr D Jackson ==== ======================================= ===================================================== b) Position/status PCA of Ms S Jackson (SVP, Global Communications and CEO Office) ==== ======================================= ===================================================== c) Initial notification/ Initial notification amendment ==== ======================================= ===================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================== a) Name GlaxoSmithKline plc ==== ======================================= ===================================================== b) LEI 5493000HZTVUYLO1D793 ==== ======================================= ===================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ======================================= ===================================================== b) Nature of the Award of Ordinary Shares under the Company's transaction Share Value Plan ==== ======================================= ===================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ======================================= ========================== ====================== GBP17.434 6,330 ======================================================================= ====================== d) Aggregated information N/A ==== Aggregated volume Price ==================================================================== ============================= e) Date of the transaction 2019-09-03 ==== ======================================= ===================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ======================================= =====================================================
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHQDLFFKKFXBBK
(END) Dow Jones Newswires
September 17, 2019 12:46 ET (16:46 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions